These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
10. [Conservative therapy of inflammatory bowel diseases]. Nagy F Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315 [TBL] [Abstract][Full Text] [Related]
11. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases. Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease and the elderly: a review. Taleban S; Colombel JF; Mohler MJ; Fain MJ J Crohns Colitis; 2015 Jun; 9(6):507-15. PubMed ID: 25870198 [TBL] [Abstract][Full Text] [Related]
13. [Inflammatory bowel disease (IBD): development in the area of diagnosis and treatment]. Jergens AE Tijdschr Diergeneeskd; 2002 May; 127(9):300-1. PubMed ID: 12046452 [No Abstract] [Full Text] [Related]
14. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915 [TBL] [Abstract][Full Text] [Related]
15. Pancreatitis in inflammatory bowel diseases. Pitchumoni CS; Rubin A; Das K J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199 [TBL] [Abstract][Full Text] [Related]
16. [Changing treatment of inflammatory bowel diseases]. Karvonen AL; Matikainen M; Turunen U Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809 [No Abstract] [Full Text] [Related]
17. Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument. Cheng H; Ma Z; Yu B; Liu X; Tian C; Zhong X; Zhao L J Clin Pharm Ther; 2021 Aug; 46(4):1155-1165. PubMed ID: 33768598 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374 [TBL] [Abstract][Full Text] [Related]
19. Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study. Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS J Pediatr Gastroenterol Nutr; 2018 May; 66(5):e122-e126. PubMed ID: 29077643 [TBL] [Abstract][Full Text] [Related]
20. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Metge CJ; Blanchard JF; Peterson S; Bernstein CN Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]